Examkin

Soru

Zorluk: OrtaPharmacologic Interventions

A 34-year-old woman is brought to the emergency department by ambulance. Her husband reports she suddenly fell to the floor and began having full-body convulsions 15 minutes ago. The convulsions have been continuous without any periods of recovery. She has no known past medical history. Upon arrival, her blood pressure is 142/88 mmHg, pulse is 118/min, and oxygen saturation is 94% on a non-rebreather mask. She is unresponsive, diaphoretic, and exhibiting continuous generalized tonic-clonic movements. Point-of-care blood glucose is 98 mg/dL. Two large-bore peripheral intravenous lines are rapidly established. Arrange the following pharmacologic interventions in the correct sequential order for the escalating management of this patient's condition, starting from the initial recommended therapy to treatments for refractory cases.

  1. 1Intravenous lorazepam
  2. 2Intravenous fosphenytoin
  3. 3Intravenous propofol continuous infusion
  4. 4Intravenous pentobarbital continuous infusion

Cevap

The correct sequence for managing status epilepticus is to start with intravenous lorazepam, followed by intravenous fosphenytoin, then intravenous propofol continuous infusion, and finally intravenous pentobarbital continuous infusion for super-refractory cases.
The management of status epilepticus follows a strict time-dependent protocol. Phase 1 (0-5 minutes) requires a fast-acting benzodiazepine like lorazepam to immediately halt the seizure. Phase 2 (20-40 minutes) involves loading a longer-acting antiepileptic drug like fosphenytoin to maintain seizure suppression. Phase 3 (40-60 minutes) addresses refractory status epilepticus with continuous anesthetic infusions such as propofol, which necessitates securing the airway. Finally, if seizures remain uncontrolled (super-refractory), severe interventions like a continuous pentobarbital infusion are utilized to induce a barbiturate coma.

Adım Adım Çözüm

1
Identify the clinical presentation and duration.
The patient is experiencing generalized tonic-clonic status epilepticus (continuous seizure activity >5 minutes).
Recognizing status epilepticus is critical because it is a neurologic emergency requiring immediate, protocolized pharmacologic escalation to prevent irreversible brain injury.
2
Determine the Phase 1 (initial) pharmacologic intervention.
Select intravenous lorazepam.
Intravenous benzodiazepines are the first-line agents because they rapidly cross the blood-brain barrier to enhance GABAergic inhibition and abort acute seizure activity.
3
Determine the Phase 2 (second-line) pharmacologic intervention.
Select intravenous fosphenytoin.
Once a benzodiazepine is given, a longer-acting non-benzodiazepine antiepileptic drug must be loaded to prevent seizure recurrence, as benzodiazepines redistribute rapidly out of the central nervous system.
4
Determine the Phase 3 (refractory) pharmacologic intervention.
Select intravenous propofol continuous infusion.
If clinical or electrographic seizures persist after Phase 1 and 2 therapies, the patient has refractory status epilepticus. This requires intubation and mechanical ventilation to facilitate continuous infusions of general anesthetics.
5
Determine the final (super-refractory) pharmacologic intervention.
Select intravenous pentobarbital continuous infusion.
For seizures that continue despite adequate anesthetic infusions for 24 hours (super-refractory status epilepticus), deeply suppressive barbiturate coma is the therapy of last resort.

Anahtar Kavram

The protocolized, sequential pharmacologic escalation in the management of status epilepticus.
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru